Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent

Authors

Institutions

Publication Details

Journal
Naunyn-Schmiedeberg s Archives of Pharmacology
Published
2025-11-26
DOI
https://doi.org/10.1007/s00210-025-04780-x
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent

Kamal A. Badr, Mamdouh R. Rezk, Aya M. AbdelMagid, A. H. Hosny
1 citations
Naunyn-Schmiedeberg s Archives of Pharmacology
Diabetes Treatment and Management
1.29
article

Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent

Kamal A. Badr, Mamdouh R. Rezk, Aya M. AbdelMagid, A. H. Hosny
article en
1 citations

Abstract

No abstract available for this paper.
Naunyn-Schmiedeberg s Archives of Pharmacology
Cairo University (EG), Egyptian Consulting & Trading Co. Ltd (EG), Minia University (EG)
Science and Technology Development Fund
Openalex Percentile: Top 13%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.